Ohsu

Last week, the Trump administration canceled key panels organized by the National Institutes of Health. The cancellations raise concerns among local researchers and healthcare professionals in Oregon about potential cuts to vital research funding. Currently, over $500 million in NIH-funded projects are ongoing in Oregon, supporting more than 5,000 jobs.

In a wide-ranging interview with OPB, Druker discussed the work he hopes to do in the future, and the message he wants to send to Oregon Health & Science University.

Dr. Brian Druker may be best known for his pioneering work on the cancer drug Gleevec, which dramatically increased the survival rate for a type of leukemia.

Stadum previously served as general counsel to OHSU and chief operating officer for the Knight Cancer Institute.

Oregon Governor Tina Kotek said she wants a more transparent process for selecting the next OHSU president.

OHSU’s board of directors intends to quickly replace President Danny Jacobs, who is resigning. Oregon Gov. Tina Kotek's office wants the board to take more time.

OHSU relies heavily on a single supplier, Baxter International, which suffered major damage to a critical North Carolina factory in Hurricane Helene.

The U.S. Surgeon General has issued an advisory saying stress from parenting is a public health issue. We'll hear from an OHSU physician to learn how parents can deal with stress.

A retired emergency medical doctor who volunteers for the Physicians Committee for Responsible Medicine joins us to share her views on best practices for surgical training.

We hear about OHSU's efforts to develop a universal flu vaccine that would guard against ever-changing strains of the seasonal flu and other flu viruses.